Obsidian Therapeutics

Obsidian Therapeutics

  • 51-200 Employees
  • Series C on 2024-04

Careers at Obsidian Therapeutics


About Obsidian Therapeutics

Obsidian Therapeutics is a leading biotechnology company pioneering in the field of precision cell and gene therapy. Utilizing its proprietary cytoDRiVE® platform, the company engineers precision medicines by harnessing the power of regulated therapeutic proteins. Obsidian's innovative programs, including the OBX-115, target advanced melanoma and have been recognized by the FDA with both Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations. Their pipeline of investigational therapies is designed to offer new hope for patients with unmet medical needs.